| References |
|
|
Bartlett K and
Eaton S
(2004)
Mitochondrial beta-oxidation.
European Journal of Biochemistry
271:
462–469.
|
|
|
Bennett MJ,
Russell LK,
Tokunaga C et al.
(2006)
Reye-like syndrome resulting from novel missense mutations in mitochondrial medium- and short-chain l-3-hydroxy-acyl-CoA dehydrogenase.
Molecular Genetics and Metabolism
89:
74–79.
|
|
|
Bennett MJ,
Weinberger MJ,
Kobori JA,
Rinaldo P and
Burlina AB
(1996)
Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation.
Pediatric Research
39(1):
185–188.
|
|
|
Bertrand C,
Largilliere C,
Zabot MT et al.
(1993)
Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts.
Biochimica et Biophysica Acta
1180:
327–329.
|
|
|
Bhala A,
Willi SM,
Rinaldo P et al.
(1995)
Clinical and biochemical characterization of short-chain acyl-coenzyme A dehydrogenase deficiency.
Journal of Pediatrics
126:
910–915.
|
|
|
Bonnefont JP,
Djouadi F,
Prip-Buus C et al.
(2004)
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.
Molecular Aspects of Medicine
25:
495–520.
|
|
|
Bremer J
(1983)
Carnitine–metabolism and functions.
Physiological Reviews
63:
1420–1480.
|
|
|
Brown NF,
Hill JK,
Esser V,
Kirkland JL et al.
(1997)
Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation: inter-tissue and inter-species expression of CPT I and CPT II enzymes.
The Biochemical Journal
327(Pt 1):
225–231.
|
|
|
Clayton PT,
Eaton S,
Aynsley-Green A et al.
(2001)
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.
Journal of Clinical Investigation
108:
457–465.
|
|
|
De Leon DD and
Stanley CA
(2007)
Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.
Nature Clinical Practice. Endocrinology & Metabolism
3:
57–68.
|
|
|
Den Boer ME,
Dionisi-Vici C,
Chakrapani A et al.
(2003)
Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement.
Journal of Pediatrics
142:
684–689.
|
|
|
Den Boer ME,
Wanders RJ,
Morris AA et al.
(2002)
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients.
Pediatrics
109:
99–104.
|
|
|
Derks TG,
Duran M,
Waterham HR et al.
(2005)
The difference between observed and expected prevalence of MCAD deficiency in The Netherlands: a genetic epidemiological study.
European Journal of Human Genetics
13:
947–952.
|
|
|
DiMauro S and
DiMauro PM
(1973)
Muscle carnitine palmityltransferase deficiency and myoglobinuria.
Science
182:
929–931.
|
|
|
Ensenauer R,
He M,
Willard JM et al.
(2005)
Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids.
Journal of Biological Chemistry
280:
32309–32316.
|
|
|
Esser V,
Brown NF,
Cowan AT,
Foster DW and
McGarr JD
(1996)
Expression of a cDNA isolated from rat brown adipose tissue and heart identifies the product as the muscle isoform of carnitine palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform expressed in both white (epididymal) and brown adipocytes.
The Journal of Biological Chemistry
271(12):
6972–6977.
|
|
|
Filling C,
Keller B,
Hirschberg D et al.
(2008)
Role of short-chain hydroxyacyl CoA dehydrogenases in SCHAD deficiency.
Biochemical and Biophysical Research Communications
368(1):
6–11.
|
|
|
Furuta S,
Kobayashi A,
Miyazawa S and
Hashimoto T
(1997)
Cloning and expression of cDNA for a newly identified isozyme of bovine liver 3-hydroxyacyl-CoA dehydrogenase and its import into mitochondria.
Biochimica et Biophysica Acta
1350(3):
317–324.
|
|
|
Gregersen N,
Andresen BS,
Pedersen CB et al.
(2008)
Mitochondrial fatty acid oxidation defects–remaining challenges.
Journal of Inherited Metabolic Disorders
31:
643–657.
|
|
|
Grosse SD,
Khoury MJ,
Greene CL et al.
(2006)
The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.
Genetics in Medicine
8:
205–212.
|
|
|
He M,
Rutledge SL,
Kelly DR et al.
(2007)
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
American Journal of Human Genetics
81:
87–103.
|
|
|
He XY and
Yang SY
(2007)
3-hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder.
Molecular Genetics and Metabolism
91:
205–206.
|
|
|
Hoffman JD,
Steiner RD,
Paradise L et al.
(2006)
Rhabdomyolysis in the military: recognizing late-onset very long-chain acyl co-A dehydrogenase deficiency.
Military Medicine
171(7):
657–658.
|
|
|
Ijlst L,
Ruiter JP,
Hoovers JM et al.
(1996)
Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene.
Journal of Clinical Investigation
98:
1028–1033.
|
|
|
Jackson S,
Kler RS,
Bartlett K et al.
(1992)
Combined enzyme defect of mitochondrial fatty acid oxidation.
Journal of Clinical Investigation
90:
1219–1225.
|
|
|
Jethva R,
Bennett MJ and
Vockley J
(2008)
Short-chain acyl-coenzyme A dehydrogenase deficiency.
Molecular Genetics and Metabolism
95:
195–200.
|
|
|
Koeberl DD,
Young SP,
Gregersen NS et al.
(2003)
Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening.
Pediatric Research
54:
219–223.
|
|
|
Kompare M and
Rizzo WB
(2008)
Mitochondrial fatty-acid oxidation disorders.
Seminars in Pediatric Neurology
15:
140–149.
|
|
|
Lehnert W,
Wendel U,
Lindenmaier S and
Bohm N
(1982)
Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings.
European Journal of Pediatrics
139:
56–59.
|
|
|
Longo N,
Amat di San Filippo C and
Pasquali M
(2006)
Disorders of carnitine transport and the carnitine cycle.
American Journal of Medical Genetics Part C, Seminars in Medical Genetics
142C:
77–85.
|
|
|
book
Nelson NL and
Cox MM
(2005)
Lehninger, Principles of Biochemistry,
4th edn.
New York: WH Freeman and Company.
ISBN-0-7167-4339-6.
|
|
|
book
Nyhan WL and
Ozand PT
(1998)
"Disorders of fatty acid oxidation".
In: Nyhan WL and
Ozand PT (eds)
Atlas of Metabolic Diseases,
pp. 209–258.
London: Chapman and Hall.
|
|
|
Oey NA,
Den Boer ME,
Wijburg FA et al.
(2005)
Long-chain fatty acid oxidation during early human development.
Pediatric Research
57(6):
755–759.
|
|
|
Oey NA,
Ruiter JP,
Ijlst L et al.
(2006)
Acyl-CoA dehydrogenase 9 (ACAD 9) is the long-chain acyl-CoA dehydrogenase in human embryonic and fetal brain.
Biochemical and Biophysical Research Communications
346:
33–37.
|
|
|
Przyrembel H,
Wendel U,
Becker K et al.
(1976)
Glutaric aciduria type II: report on a previously undescribed metabolic disorder.
Clinica Chimica Acta
66:
227–239.
|
|
|
other
Rajkumar C,
Ban MR,
Cao H et al.
(2009) Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I. Journal of Lipid Research [Epub ahead of print].
|
|
|
Rakheja D,
Bennett M J and
Rogers BB
(2002)
Long-chain L-3-hydroxyacyl-coenzyme a dehydrogenase deficiency: a molecular and biochemical review. Laboratory investigation.
Journal of Technical Methods and Pathology
82:
815–824.
|
|
|
Rinaldo P,
Matern D and
Bennett MJ
(2002)
Fatty acid oxidation disorders.
Annual Review Physiology
64:
477–502.
|
|
|
Roomets E,
Kivela T and
Tyni T
(2008)
Carnitine palmitoyltransferase I and Acyl-CoA dehydrogenase 9 in retina: insights of retinopathy in mitochondrial trifunctional protein defects.
Investigative Ophthalmology & Visual Science
49:
1660–1664.
|
|
|
Sierra AY,
Gratacos E,
Carrasco P et al.
(2008)
CPT1c is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity.
Journal of Biological Chemistry
283:
6878–6885.
|
|
|
Sigauke E,
Rakheja D,
Kitson K and
Bennett MJ
(2003)
Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review; Laboratory investigation.
Journal of Technical Methods and Pathology
83(11):
1543–1554.
|
|
|
Slitt AL,
Cherrington NJ,
Hartley DP et al.
(2002)
Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels.
Drug Metabolism and Disposition
30:
212–219.
|
|
|
Spiekerkoetter U,
Schwahn B,
Korall H et al.
(2000)
Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine/acylcarnitine analysis in blood spots.
Acta Paediatrica
89:
492–495.
|
|
|
Stanley CA,
Hale DE,
Berry GT et al.
(1992)
Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane.
New England Journal of Medicine
327:
19–23.
|
|
|
Tamai I,
Ohashi R,
Nezu JI et al.
(2000)
Molecular and functional characterization of organic cation/carnitine transporter family in mice.
Journal of Biological Chemistry
275:
40064–40072.
|
|
|
Tyni T and
Pihko H
(1999)
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Acta Paediatrica
(Oslo, Norway: 1992)
88:
237–245.
|
|
|
Tyni T,
Paetau A,
Strauss AW et al.
(2004)
Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Pediatric Research
56:
744–750.
|
|
|
Ushikubo S,
Aoyama T,
Kamijo T et al.
(1996)
Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits.
American Journal of Human Genetics
58:
979–988.
|
|
|
Vockley J and
Whiteman DA
(2002)
Defects of mitochondrial beta-oxidation: a growing group of disorders.
Neuromuscular Disorders
12:
235–246.
|
|
|
Voermans NC,
van Engelen BG,
Kluijtmans LA,
Stikkelbroeck NM and
Hermus AR
(2006)
Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency.
The American Journal of Medicine
119(2):
176–179.
|
|
|
Von Dobeln U
(1993)
Fatty acid oxidation defects.
Acta Paediatrica
82(389):
88–90.
|
|
|
Wanders RJ,
Duran M,
Ijlst L et al.
(1989)
Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase.
Lancet
2:
52–53.
|
|
|
Wanders RJ,
Ijlst L,
Poggi F et al.
(1992)
Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation.
Biochemical and Biophysical Research Communications
188:
1139–1145.
|
|
|
Wilcken B,
Haas M,
Joy P et al.
(2007)
Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in australia: a cohort study.
Lancet
369(9555):
37–42.
|
|
|
Wolfgang MJ,
Cha SH,
Millington DS et al.
(2008)
Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight.
Journal of Neurochemistry
105:
1550–1559.
|
|
|
Yang SY,
He XY and
Schulz H
(2005)
3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease.
FEBS Journal
272:
4874–4883.
|
| Further Reading |
|
|
Bruno C and
Dimauro S
(2008)
Lipid storage myopathies.
Current Opinion in Neurology
21:
601–606.
|
|
|
Holloway GP,
Luiken JJ,
Glatz JF et al.
(2008)
A Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
Acta Physiologica (Oxford)
194:
239–309.
|
|
|
Lafort P,
Acquaviva-Bourdain C,
Rigal O et al.
(2009)
Diagnostic assessment and long-term follow-up of 13 patients with very long-chain acyl-coenzyme A dehydrogenase deficiency (VLCAD) deficiency.
Neuromuscular Disorders
19:
324–329.
|
|
|
Modre-Osprian R,
Osprian I,
Tilg B et al.
(2009)
Dynamic simulations on the mitochondrial fatty acid beta-oxidation network.
BMC Systems Biology
3:
2.
|
|
|
Pederson CB,
K lvraa S,
Klvraa A et al.
(2008)
The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level.
Human Genetics
124:
43–56.
|
|
|
Saggerson D
(2008)
Malonyl-CoA: a key signalling molecule in mammalian cells.
Annual Review of Nutrition
28:
253–272.
|
|
|
other
Spiekerkoetter U,
Lindner M,
Santer R et al.
(2009) Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. Journal of Inherited Metabolic Disease.
|
